The U.S. announces $46 million to develop new technologies for exploring the brain.
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
One of the inventors of gene editing says scientists should proceed cautiously before testing it in people.
Record number of genomes being decoded, but cost of DNA sequencing might not fall much further, says Illumina president.
A DNA sequencer the size of a cell phone could change where, and how, gene research occurs.
Can genome-editing technology revive the idea of genetically modified livestock?
Scientists are hunting for the genetic basis of suicide and developing suicide DNA tests.
He watched his brother die from a cancer no drug could cure. Now one of the world’s most renowned cancer researchers says it’s time for Plan B.
Gene research and Silicon Valley-style computing are starting to merge.
The world’s largest genome project will be carried out on instruments from the California sequencing company.
A way of capturing cancer cells from the bloodstream opens a new front in personal cancer treatment.